Drug – bio-affecting and body treating compositions – Designated organic nonactive ingredient containing other... – Solid synthetic organic polymer
Reexamination Certificate
2006-05-16
2006-05-16
Stucker, Jeffrey (Department: 1648)
Drug, bio-affecting and body treating compositions
Designated organic nonactive ingredient containing other...
Solid synthetic organic polymer
C514S772100, C514S773000, C530S300000, C530S324000, C424S078070, C424S185100, C424S186100, C424S188100
Reexamination Certificate
active
07045552
ABSTRACT:
Provided is a pharmaceutical composition comprising a solution comprised of synthetic peptide in a final concentration of not less than 70 mg/ml in admixture with a polyol; wherein the synthetic peptide is an HIV fusion inhibitor, and wherein the polyol is in a final concentration of no less than 5 weight % and no more than 75 weight % of the pharmaceutical composition. Also provided is a synthetic peptide-containing pharmaceutical composition as a unit dose comprising an aqueous formulation comprised of synthetic peptide in a final concentration of not less than 70 mg/ml in admixture with a polyol; wherein the synthetic peptide is an HIV fusion inhibitor, and wherein the polyol is in a final concentration of no less than 5 weight % and no more than 75 weight % of the pharmaceutical composition. Further provided is a method of treating HIV infection by administering to an HIV-infected individual a pharmaceutical composition according to the present invention.
REFERENCES:
patent: 5462863 (1995-10-01), Hsieh et al.
patent: 5464933 (1995-11-01), Bolognesi et al.
patent: 5589167 (1996-12-01), Cleland et al.
patent: 5656480 (1997-08-01), Wild et al.
patent: 6004549 (1999-12-01), Reichert et al.
patent: 6143314 (2000-11-01), Chandrashekar et al.
patent: 6348568 (2002-02-01), Barney et al.
patent: 6573078 (2003-06-01), Wild et al.
patent: 2004/0076602 (2004-04-01), Harris
Coombes et al. “Biodegradable polymeric microparticles of drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments”, Biomaterials, vol. 18, Issue 17 (Sep. 199.
Middaugh et al., “Protein Solubility”, Chapter 4 in “Stability of Protein Pharmaceuticals”, edited by Ahern and Manning. Plenum Press, 1992, pp. 109-113.
Middaugh et al., “Determination of the apparent thermodynamic activities of saturated protein solutions”, 1979, pp. 367-370, vol. 254, No. 3. The Journal of Biological Chemistry.
Bray Brian
Di Jie
Heilman David
Nelson M. Bud
Stucker Jeffrey
Trimeris, Inc.
LandOfFree
Pharmaceutical composition for improved administration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for improved administration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for improved administration of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3570637